Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors-Reference-Cited by-同舟云学术

Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors

Published:2017-01 Issue: Volume:256 Page:134-145
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Arca Marcello^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference103 articles.

1. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment;Rader;J. Clin. Investig.,2003

2. Familial hypercholesterolemia;Goldstein,2001

3. A receptor-mediated pathway for cholesterol homeostasis;Brown;Science,1986

4. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver;Park;J. Biol. Chem.,2004

5. Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor;Sorrentino;Curr. Opin. Lipidol.,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic control, cardiovascular profile, and adherence to the Mediterranean diet in a familial hypercholesterolemia cohort in a Public Health Program;NUTR HOSP;2020

2. Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia;Cardiovascular Drugs and Therapy;2019-02

3. Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial;Journal of Clinical Lipidology;2019-01

4. Identifying patients with familial hypercholesterolemia using data mining methods in the Northern Great Plain region of Hungary;Atherosclerosis;2018-10

5. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease;Clinical Cardiology;2018-08